.ANALYSIS HIGHLIGHT.06 August 2024.
A sizable randomized controlled test along with cisgender girls highlights the problems of fidelity to a daily oral preexposure prophylaxis regiment and also displays that twice-yearly treatment of lenacapavir can keep successful HIV prevention levels over 6 months.